Mar 04, 2015 8:05am EST Matinas BioPharma to Present at the 27th Annual ROTH Conference on March 11, 2015
Feb 05, 2015 8:05am EST Matinas BioPharma to Present at the 17th Annual BIO CEO & Investor Conference on February 9, 2015
Jan 30, 2015 8:25am EST Matinas BioPharma Establishes Lipid-Based, Anti-Infective Platform, With Acquisition of Aquarius BioTechnologies Inc.
Jan 07, 2015 7:35am EST Matinas BioPharma to Present at the Biotech Showcase 2015 Conference on January 14, 2015
Dec 23, 2014 8:05am EST Matinas BioPharma Provides Update on Clinical Development Program for MAT9001 Following FDA Feedback on IND Submission
Nov 24, 2014 7:05am EST Matinas BioPharma Appoints Leading Clinical Lipid Specialist and Metabolism Researcher, Kevin C. Maki, Ph.D., to Scientific Advisory Board
Nov 12, 2014 7:35am EST Matinas BioPharma Commences Dosing in First Human Trial of Lead Product Candidate MAT9001
